Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations

Not Applicable

Completed

• Conditions: Vaccine Preventable Disease
• Interventions: Other: Educational, culturally appropriate COVID-19 messages

• Registration Number: NCT04765839
• Lead Sponsor: Mayo Clinic

Brief Summary

A cluster randomized trial will be conducted prior to widespread vaccine availability to the general public. Community-informed COVID-19 vaccine messages will be disseminated to participants. At baseline, 2 weeks and 4 weeks, the study team will survey participants to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Detailed Description

A cluster randomized trial with 80 participants from the social networks of 8 CLs will be conducted prior to widespread vaccine availability to the general public. Four CLs and social networks (cluster of 10 per network) will be randomly assigned to receive the intervention immediately or after a delay of 2 weeks. Intervention participants will be invited to a closed social media group on the platform of their choice. CLs, selected for trustworthiness within vulnerable populations, will disseminate community-informed COVID-19 vaccine messages to members of their social networks and engage in bidirectional communication with CEnR partners to refine messages. At baseline, 2 weeks and 4 weeks, participants will be surveyed to assess knowledge and attitudes about COVID-19 vaccines, including intention to be vaccinated.

Study Timeline

• Study First Submitted: 2021-02-02
• Study Start: 2021-02-12
• Study First Submitted QC: 2021-02-19
• Study First Posted: 2021-02-23
• Primary Completion: 2021-04-03
• Study Completion: 2021-04-03
• Status Verified: 2021-07
• Last Update Submitted: 2021-07-28
• Last Update Posted: 2021-07-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

• Self-identification within a CLs social network
• Age 18 or greater
• Functional internet access.

Read More

Exclusion Criteria

• Does not self-identify within a CLs social network
• Is under the age of 18
• Does not have functional internet access.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Intervention Arm - Receives COVID-19 Vaccine messages	Educational, culturally appropriate COVID-19 messages	Group to receive COVID-19 Vaccine messages during the first two weeks of the study.
Delayed Intervention Arm	Educational, culturally appropriate COVID-19 messages	Group to receive COVID-19 Vaccine messages during the last two weeks of the study.

Primary Outcome Measures

Name	Time	Method
COVID-19 attitudes	4 weeks	Related to perceived susceptibility and preventive measures will be assessed through 3 survey instruments, based on 7-point Likert scale.

Trial Locations

Locations (1)

Mayo Clinic; 🇺🇸 Rochester, Minnesota, United States